Lonely expert articles<br><br>Vaccination deadline March 31. In order to effectively prevent the spring A pick-up and cross-regional flow of the epidemic spread, the Municipal Health Bureau from March 5 onwards, the migrant workers in Beijing to carry out a vaccination immunization work, to maximize the effect of the vaccine, vaccination is not vaccinated A A flu vaccine and no contraindications to the vaccine migrant workers in Beijing. Vaccination is the city's range of construction sites, manufacturing enterprises,sac en lin vanessa bruno, building materials market,vanessa bruno sacs, wholesale markets, bazaars, hotels, shopping malls,Trousse Vanessa Bruno, entertainment, domestic service, catering companies, medical institutions, transportation, and other units migrant workers in Beijing: an international Hualan Hua Lan Bio-depth study of people who slander Hualan are detractors. Overtime multi-month, double-salary employees are issued. Seen the company's performance is indeed a guarantee. International market has opened the door a steady stream of orders from the United Nations. Now the company has contacted and WHO consultations, because it is not capable of producing so many vaccines and blood products. First, because the production line already in the running for saturation. Second, the state repeatedly to access the inspection of the company, which has national general secretary and other central leaders and provincial party secretary, and many other senior leaders, the company hopes to fight domestic and international leader in vaccines and blood products. WHO Joint Unit orchid China also favored a plus, hope Hualan Cheng for WHO's key partners, such matters have reached a preliminary agreement. Orders from the WHO to be seen. If you open the door to international markets,Volume I first joined the Grand Chapter XV with victimsac vanessa bruno pas cher, the company is already more than just a domestic listed companies, but rather a large international biopharmaceutical company, which is also the country expect. Because this area is no such Chinese companies. So the company is implementing an international biopharmaceutical research and application of large platform program. Companies in the technology sector has made a breakthrough. In Beijing, Nanjing, Shanghai, Chengdu and Shenzhen, has R & D centers, many of which are confidential agency agreement, as it relates to technology secrets, the other seems to have R & D institutions in the United Kingdom, which requires further tap the message. Why do not we think about why the company just attack the H1N1 flu when vaccines pioneered makes other domestic and international shame those so-called big companies! This is the result of deep technical reserves. Now this is the payback period of these studies. The company is also currently in the listed companies are small-scale, which is extremely inconsistent with the company's current development, both from the state or from the company itself knows this, so in recent years, the company will conduct an annual ex bonus shares, the company became international and domestic large biological products company can be expected. In addition, the company invested a lot of real estate projects in previous years have made great benefits, now is the high returns when the leadership of the company intends to use these extra high returns to expand the size of the company, Shenzhen, Dongguan, Suzhou, Guangxi, Sichuan are already in the planning and implementation. We see brokers and media coverage are all lagging. Understand this industry knows that an interview is approved to last post almost need three months. If we really want to know to change the company, the best way is to personally investigate. Yesterday, the province's scientific and technological work conference held in Zhengzhou, after the meeting, the Provincial Science and Technology Department Director Zhao Chen accepted an exclusive interview with this reporter, revealed one after another surprise, people lamented the power of technology. Interview guests: Science and Technology Department of Henan Province Zhao Chen Interview Time: February 25 Interview Location: Henan Science and Technology Agency chief reporter Liang Xinhui reporter Zhao Yuan / Wen Qiu Qi / Chart giant Jack came to congratulate Hu Jintao instructed reporters: major scientific and technological Specific scientific and technological work is the highlight of the province last year, some of the projects achieved a major breakthrough, can explain the circumstances? Zhao Chen: XJ Group, the high level group assumed the key technology of UHV power transmission equipment in the world, the highest voltage level of the first and longest transmission distance of 800,000 volts Xiangjiaba - Shanghai HVDC Project successfully applied, order to obtain the total contract amount reached 50 billion yuan. In addition, the implementation of large Zheng coal mining hydraulic support high reliability and electro-hydraulic control system, developed the world's largest mining height of 7 m hydraulic support, and the capture of core technology electro-hydraulic control system. Reporter: large mining hydraulic support high reliability and electro-hydraulic control system, that it is very hard to pronounce, can you explain popular? Zhao Chen: popular that when the system is like coal roadway support, Jack. For a long time, China's thick seam mining, the general height of only 5 meters,, and 5 meters above the coal resources wasted. Therefore, the development of large mining height stent technology a top priority. May 1, 2007, General Secretary Hu Jintao inspected the Zhengzhou Coal Mining Machinery, he hoped Zheng coal must find ways to put research electro-hydraulic control system down. June of that year, Zheng coal on the formation of hydraulic engineering center, invested 50 million yuan for the electro-hydraulic control system localization research. Last year, Zheng coal developed the world's largest mining height of 7 m hydraulic support, and the capture of core technology electro-hydraulic control system, the completion of the General Secretary Hu Jintao to the scientific community tasks. General Secretary Hu Jintao specifically handwritten instructions would like to congratulate the table. Now, the project has reached 3.52 billion yuan of orders, in short supply. Develop therapeutic hepatitis B vaccine will be possible to cure hepatitis Reporter: You said, Xinxiang Hualan therapeutic hepatitis B vaccine has been through a major science and technology projects, therapeutic and prophylactic hepatitis B vaccine What is the difference? Zhao Chen: Traditional hepatitis B vaccine only for people not infected with hepatitis B virus, usually only prevention<br><br>: Reporter: You said, Xinxiang Hualan therapeutic hepatitis B vaccine has been through a major science and technology projects, therapeutic and prophylactic hepatitis B vaccine What is the difference? Zhao Chen: Traditional hepatitis B vaccine only for people not infected with hepatitis B virus, generally only preventive effect, while the treatment of hepatitis B vaccine is used for people already infected with the hepatitis B virus, hepatitis B virus can play an inhibitory effect. Reporter: The hepatitis B vaccine can cure you? When can I come? Zhao Chen: Testing found that treatment of hepatitis B vaccine could play an inhibitory effect on hepatitis B virus. However, how this inhibition, the ability to remove the body of the hepatitis B virus is not to say, depends on further clinical trials results. Vaccine trials currently still in development, when the advent of hard to say. Reported that, despite the three influenza virus may be transmitted simultaneously in the northern hemisphere, but H1N1 influenza virus may still be the dominant flu virus. WHO recommended in the report, the three northern hemisphere countries should use the virus to develop seasonal flu vaccines. WHO pandemic influenza Keiji Fukuda, Special Adviser said after the meeting, national health departments to decide how to use these three viruses to develop vaccines that can contain both components of the three viruses in a vaccine, you can also use them Three different vaccines were developed. Anjie Shao Mao,vanessa bruno sacs, the Ministry of Health attaches great importance to the prevention and control of bird flu, according to the relevant plan requirements, firmly grasp the prevention, control and treatment of three key links, serious plans, and implement prevention and control work. Ministry of Health and Ministry of Agriculture, Forestry merchants every year together will avian flu and animal avian flu situation, it puts forward the prevention and control measures, and promptly issued a circular, layout prevention and control work. December 2008, the Ministry of Health issued the Office of the Ministry of Health to strengthen bird flu prevention and control of acute infectious disease of the notice; January 23, 2009, the Ministry of Health issued on the strengthening of the General Office of the Ministry of Health human infection with highly pathogenic avian influenza prevention and control work of the emergency notification. For the presence of viral contamination of live poultry business market situation, the Ministry of Health jointly agriculture,sac vanessa bruno pas cher, industry and commerce department issued a live poultry operations to increase market supervision, a really good job of bird flu prevention and control work of the notice. Meanwhile, the Ministry of Health also organizational strength, guidance, and support-related cases of provincial health departments for treatment and epidemic prevention and control work. Ministry of Health leaders personally deployment, requiring local health departments in human bird flu prevention and control work should be done early diagnosis, early reporting; accomplish history of exposure to poultry found unexplained pneumonia suspected cases reported immediately to improve the treatment success rate, reduce the spread of the epidemic spread of risk to gain time. My Department is also actively coordinating relevant units of Tamiflu antiviral serum and other drugs. Meanwhile, the Department promptly and objectively to the community, the World Health Organization, announced on national and regional outbreaks. Experts believe that bird flu can preventable, controllable, and curable. Health, agriculture, military, and Chinese Academy of Sciences and other related departments have been emphasis on human avian influenza, bird flu prevention and control of basic and applied scientific research. At present, China's self-developed human bird flu vaccine clinical trials have been completed and obtained production licenses. Antiviral serum and other new treatment techniques have been three cases of successful treatment of cases played a role. With our knowledge of human avian influenza mastery increase, human bird flu prevention and control ability and level will further improve. At the same time, raise public awareness and ability to prevent disease, bird flu prevention and control work is a very important component. Public health authorities should publicize the science of human avian influenza prevention and control knowledge, educate the public does not contact with dead poultry, guide the public in developing a healthy behavior etc. And recommended that governments and relevant departments to strengthen market supervision and management of live poultry from the source prevention and control of bird flu. Next, the Ministry of Health will continue to strengthen agriculture, industry and commerce, quality inspection, forestry and other multi-sectoral cooperation between, improve information exchange, resource sharing, and other cooperation measures linkage mechanism. And joint-related departmental<br><br>: As an old shares is willing to share with you the ups and downs in the stock market 500 people plus my old stock exchange group 82,374,253 shares at a flow of drugs Tamiflu says there are three domestic production, the sea is medicine obvious benefit: A stream is an effective drug Tamiflu and Relenza, patent medicine companies are Roche and GlaxoSmithKline. Hisun domestic production of Tamiflu intermediate and upper Yangtze River Pharmaceutical Group manufactures Tamiflu drug to protect the flu can be made when sufficient supply of Tamiflu. With the increase in the number of infections, the government purchases will rise to Tamiflu, Tamiflu intermediates manufacturer Hisun will obviously benefit from the drug group yields a smaller, second benefit. Hualan, Tiantan Biological entered a substantive stage of profitability, stocks have investment opportunities: We are two hypothetical scenarios: Scenario one: the end of 2009 before the National Order of 130 million, 10 companies will supply national demand full production, Westlands biological and Tiantan Biological received national orders will exceed our expectations, 0910 annual results will be very flexible. Scenario two: the end of 2009 before the National Order of 65 million, only 13 million extreme, Hualan and Tiantan Biological production orders outside the country unless there is a larger supply surplus. As the global supply of flu vaccine shortage, domestic enterprises flu vaccine may be exported to overseas markets, access to higher profits. We consider two scenarios, a flu vaccine companies will benefit: The company today announced receipt of the Ministry of 12,250,470 flu vaccine production plans, require the company to be completed before the end of January 2010 production, batch release completed before the end of February. Comments are as follows: Company A flu vaccine accounted for 40% of the purchasing and storage: As of now the company to obtain a total 52,250,470 flu vaccine orders, accounting for the Ministry for 40% of the total number of orders. According to the inspection of the data, as of December 31, 2009 Company had 29,740,000 through a flu vaccine batch release is expected to be recognized as a 2009 flu vaccine revenues. A flu vaccine allocated to the provinces, the governments at all levels have gradually paid back to the enterprise, the company expects annual cash flow 20,092,010 performance will be very good. Blood products industry leader, Chongqing subsidiary has been put into trial production: The company is the largest amount of domestic investment plasma, blood products, the most abundant types of enterprises, blood products industry leader. Chongqing subsidiary of blood products designed production capacity of 1,000 tons cast slurry, which was January 11 put into trial production, the company further enhanced industry leading position. There are two companies in Chongqing normal plasma plasma collection stations, two pulp stand construction, we expect in Chongqing will build five new plasma stations over the next 23 years the number of companies plasma collection stations will be over 20. Hansenula hepatitis B vaccine market soon, the company's future will be the vaccine industry leader: We know from the SFDA website Hansenula hepatitis B vaccine company has entered the stage of administrative examination and approval, is expected to soon be granted market. 20092011 National 15 years of age replant hepatitis B vaccine, hepatitis B vaccine Hansenula after the listing of the full benefit, sales may exceed our expectations. Company's existing first domestic influenza vaccine production capacity, to fully benefit from the domestic influenza vaccination rates have increased. Flu vaccine research and development in the production of outstanding performance and establish a Hualan vaccine brand and facilitate the subsequent vaccine product sales. The company has a complete vaccine products echelon, management excellence, it will become the vaccine industry leading enterprises. 2011 results upside, maintain a target price of 100 yuan: We maintain our earnings per share 20,092,011 1.5 yuan, 2.0 yuan, 2.2 yuan, an increase of 189%,Hunan located two H7N9 avian influenza hospitals Adult Chsacs vanessa bruno prix, 34%, 10%. We have yet to consider the vaccine export earnings, but also does not consider the price of blood products, the profit forecast is still quite conservative forecast 2011 earnings upside. The company's future is a dual blood products and vaccines industry leader, should enjoy a premium valuation given 50 times 2010 earnings, target price of 100 yuan, to maintain overweight rating. Catalysts: maximum retail price increases blood products; vaccine exports; new vaccines listed: Henan Xinhua News Channel on January 22 largest river - Henan Daily reported: January 21, news came Provincial Development and Reform Commission, the province of New Hualan Hepatitis B vaccine - a vaccine Hansenula scale separation and purification, as well as new and efficient virus Jiyuan Baiyun series of biological pesticides two high-tech industrialization projects have been included in the national high-tech industry development projects and national funding grant program. This means that the province biological capability of independent innovation and upgraded to a new level. Provincial Development and Reform tech Department official said that the national total of five projects included in the national plan, the approved projects are relevant provincial (city) Development and Reform Commission jointly with the Chinese Academy of Sciences reported. New Hepatitis B vaccine - a vaccine Hansenula by the large-scale separation and purification technology Hualan Biological Engineering Co., Ltd. and the Institute of Process Engineering jointly developed this technology to solve large-scale vaccine production yield is low, the product unstable key technical issues. The total investment is 120 million yuan, the construction scale of 10 million copies, after completion of the project estimated annual sales income of 260 million yuan. Implementation of the project will be implemented with independent intellectual property rights of genetically engineered hepatitis B vaccine scale production. Henan Jiyuan Baiyun Industry Co., Ltd. and the Institute of Zoology, Chinese Academy of Sciences jointly developed new and efficient virus biological pesticide project, a total investment of 69.8 million yuan, the project will be built to achieve sales revenue of 124 million yuan, which can effectively alleviate the agricultural non-point source pollution, protect the ecological environment, and to ensure safety of agricultural products, improve the market competitiveness of agricultural products, and promote China's pesticide industry structure optimization and upgrading of great significance: SW: Hualan Kaixian plasma collection stations approved for production holdings 20100106 11:33 SW: Hualan Kaixian plasma collection stations approved for production in the gold holdings _ Online Event: Company today announced Kaixian plasma apheresis plasma collection stations to obtain a license, officially plasma collection. Kaixian is resource-rich plasma donation county: Kaixian total population of 1.6 million, more than 100,000 poor, resource-rich plasma donation. Chongqing history there have been six plasma collection stations, the local people have plasma donation based, easy to be launched plasma donation, we expect Kaixian pulp.
DavidCadogan.ca Forums » DavidCadogan.ca
Lonely expert articlessac en lin vanessa bruno
(1 post)-
Posted 12 years ago #
Reply
You must log in to post.